Literature DB >> 14759226

Intracellular proteoglycans.

Svein Olav Kolset1, Kristian Prydz, Gunnar Pejler.   

Abstract

Proteoglycans (PGs) are proteins with glycosaminoglycan chains, are ubiquitously expressed and have a wide range of functions. PGs in the extracellular matrix and on the cell surface have been the subject of extensive structural and functional studies. Less attention has so far been given to PGs located in intracellular compartments, although several reports suggest that these have biological functions in storage granules, the nucleus and other intracellular organelles. The purpose of this review is, therefore, to present some of these studies and to discuss possible functions linked to PGs located in different intracellular compartments. Reference will be made to publications relevant for the topics we present. It is beyond the scope of this review to cover all publications on PGs in intracellular locations.

Mesh：

Substances：

Year:  2004        PMID： 14759226      PMCID： PMC1224092          DOI： 10.1042/BJ20031230

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


  143 in total

Review 1.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1.

Authors:  M Ringvall; J Ledin; K Holmborn; T van Kuppevelt; F Ellin; I Eriksson; A M Olofsson; L Kjellen; E Forsberg
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

3.  N-glycans as apical sorting signals in epithelial cells.

Authors:  P Scheiffele; J Peränen; K Simons
Journal:  Nature       Date:  1995-11-02       Impact factor: 49.962

4.  Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.

Authors:  M Walter; M Plotnick; N M Schechter
Journal:  Arch Biochem Biophys       Date:  1996-03-01       Impact factor: 4.013

5.  A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I.

Authors:  K Sakai; S Ren; L B Schwartz
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

6.  Packaging of proteases and proteoglycans in the granules of mast cells and other hematopoietic cells. A cluster of histidines on mouse mast cell protease 7 regulates its binding to heparin serglycin proteoglycans.

Authors:  R Matsumoto; A Sali; N Ghildyal; M Karplus; R L Stevens
Journal:  J Biol Chem       Date:  1995-08-18       Impact factor: 5.157

7.  Heparin proteoglycans synthesized by mouse mastocytoma contain chondroitin sulphate.

Authors:  K Lidholt; I Eriksson; L Kjellén
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

8.  Regulation of rat mast cell protease 1 activity. Protease inhibition is prevented by heparin proteoglycan.

Authors:  G Pejler; L Berg
Journal:  Eur J Biochem       Date:  1995-10-01

9.  Different fate of a single reporter protein containing KDEL or KKXX targeting signals stably expressed in mammalian cells.

Authors:  G Martire; G Mottola; M C Pascale; N Malagolini; I Turrini; F Serafini-Cessi; M R Jackson; S Bonatti
Journal:  J Biol Chem       Date:  1996-02-16       Impact factor: 5.157

10.  A submembranous matrix of proteoglycans on zymogen granule membranes is involved in granule formation in rat pancreatic acinar cells.

Authors:  K Schmidt; H Dartsch; D Linder; H F Kern; R Kleene
Journal:  J Cell Sci       Date:  2000-06       Impact factor: 5.285
View more
  38 in total

1.  Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1.

Authors:  Astri J Meen; Inger Øynebråten; Trine M Reine; Annette Duelli; Katja Svennevig; Gunnar Pejler; Trond Jenssen; Svein O Kolset
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

2.  Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate.

Authors:  Kirstin Veugelers; Bruce Motyka; Ing Swie Goping; Irene Shostak; Tracy Sawchuk; R Chris Bleackley
Journal:  Mol Biol Cell       Date:  2005-11-09       Impact factor: 4.138

Review 3.  Internalization of cationic peptides: the road less (or more?) traveled.

Authors:  S M Fuchs; R T Raines
Journal:  Cell Mol Life Sci       Date:  2006-08       Impact factor: 9.261

4.  TSG-6 protein, a negative regulator of inflammatory arthritis, forms a ternary complex with murine mast cell tryptases and heparin.

Authors:  Gyorgy Nagyeri; Marianna Radacs; Sheida Ghassemi-Nejad; Beata Tryniszewska; Katalin Olasz; Gabor Hutas; Zsuzsa Gyorfy; Vincent C Hascall; Tibor T Glant; Katalin Mikecz
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

5.  Heparan sulfate 6-O-sulfotransferase isoform-dependent regulatory effects of heparin on the activities of various proteases in mast cells and the biosynthesis of 6-O-sulfated heparin.

Authors:  Md Ferdous Anower-E-Khuda; Hiroko Habuchi; Naoko Nagai; Osami Habuchi; Takashi Yokochi; Koji Kimata
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

6.  Comparative glycomics of leukocyte glycosaminoglycans.

Authors:  Chun Shao; Xiaofeng Shi; Mitchell White; Yu Huang; Kevan Hartshorn; Joseph Zaia
Journal:  FEBS J       Date:  2013-04-02       Impact factor: 5.542

Review 7.  Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators.

Authors:  Kathryn D Rodgers; James D San Antonio; Olena Jacenko
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

8.  Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice.

Authors:  Donna S Woulfe; Joanne Klimas Lilliendahl; Shelley August; Lubica Rauova; M Anna Kowalska; Magnus Abrink; Gunnar Pejler; James G White; Barbara P Schick
Journal:  Blood       Date:  2007-12-19       Impact factor: 22.113

Review 9.  Therapeutically targeting protein-glycan interactions.

Authors:  A Rek; E Krenn; A J Kungl
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

10.  Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells.

Authors:  Fang Zong; Eleni Fthenou; Nina Wolmer; Péter Hollósi; Ilona Kovalszky; László Szilák; Carolin Mogler; Gustav Nilsonne; Georgios Tzanakakis; Katalin Dobra
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.